objectives Prisons act as infectious disease reservoirs. We aimed to explore the challenges of TB control and continuity of care in prisons in Zambia.
Introduction
More than 10 million people are incarcerated worldwide at any one time, while four to six times this number passes through prisons each year [1] . The majority of inmates globally come from disadvantaged or low socio-economic backgrounds that make them vulnerable to disease even before entering prison [2] . Compounding these risk factors, the congregate and confined nature of correctional facilities and prisons place additional physiological, mental and emotional stress on inmates and prison personnel. In lowincome countries where infrastructure and environmental conditions are often poor and overcrowding common, the risk of infection with airborne infectious diseases such as tuberculosis (TB) is particularly high [3] .
Globally, the prevalence of TB in prisons is higher than that in the general population. WHO reports that prisonbased TB rates can be up to 100 times greater than those in the general population [4] . This risk is especially high in sub-Saharan Africa, where many countries experience concurrent high rates of human immunodeficiency virus (HIV) infection.
Prisons are high-risk environments for those living and working within them. They can act as a reservoir for infectious disease, weakening or undermining mainstream disease-control efforts. In low-and middle-income countries (LMICs), the estimated fraction of TB in the general population attributable to prison-based transmission is 6.3% (IQR: 1.9-17.9%) [5] . Such infection may be spread through several mechanisms: officers and affiliated personnel working in prisons, via prison visitors and by undiagnosed or inadequately treated inmates on release. Improving TB control in prisons and ensuring continuity of care thus becomes imperative for both securing the health of inmates and prison personnel and for reducing population-level disease burdens.
In Zambia, the national TB prevalence is estimated at 433/100 000 [6] ; however, comprehensive national estimates for TB prevalence in Zambian prisons do not exist. The most current data are from a TB REACH funded screening programme conducted in 2010-2011 among inmates in six of the largest of Zambia's 87 prison facilities. This programme was initiated by the Zambia Prisons Service (ZPS) and the Centre for Infectious Disease Research in Zambia (CIDRZ) in 2010 and has been previously described [7, 8] . Overall, the programme found a TB prevalence of 6428/100 000 [8] . This rate is more than 15 times that estimated for the general population and highlights an urgent need for improved TB screening, diagnosis, treatment and referral within and between prison and mainstream health services [9] . In this study, with the aim of better understanding the challenges of ensuring continuity of care in prisons setting in Zambia, we evaluated treatment outcomes for that same cohort of inmates.
Methods
This study aimed to retrospectively evaluate TB treatment outcomes for a cohort of Zambian prison inmates who received services as part of a large programme introduced by the Zambian Prisons Service and supported by the Centre for Infectious Disease Research in Zambia.
Prison setting & screening intervention
In 2010, a TB screening, diagnosis and treatment programme was implemented in six large Zambian prisons: Lusaka Central Prison, Livingstone Central Prison and the four prisons in the Kabwe Complex incorporating: Kabwe Maximum, Kabwe Medium, Kabwe Female and the Kabwe Open Air Prison. The characteristics of these facilities are summarised in Table 1 and included both maximum and medium security prisons as well as one pre-release 'farm' prison. Inmate populations varied across the six sites, with medium security facilities housing a mix of remandees (those awaiting trial) and convicts. All six prisons were filled overcapacity, most acutely at Lusaka Central (285% capacity) and Kabwe Male Maximum (283%) prisons. Only one, Kabwe Male Maximum, had a health facility inside prison walls. Inmates at the other five sites had to access services in external public primary health centres. Human resources for health in all facilities (internal and external) were extremely low (Table 1) . TB and ART treatment were provided according to current national guidelines by the internal health facility or the closest government health facility. In addition, these prisons were supported by a local NGO providing ART treatment to inmates through weekly visits under the national programme supervision. Mean age of inmates was 34 years, 95% were male and 23% were HIV-infected [8] . No information on other morbidities was collected.
To ensure as comprehensive an intervention as possible, a three-pronged approach was used. This approach has been described in full elsewhere [7, 8] but included the following: first, a routine TB entry-screening programme was established to capture all inmates entering the prison. Second, a one-time mass-screening activity was conducted to screen all inmates already within each facility. Third, a routine referral protocol was developed and implemented, by which inmates with identifiable TB symptoms were referred and screened for TB by the peer educators and programme staff. Intervention activities were designed to mirror or boost routine prison TB control systems which included nominal provision of TB screening of inmate on entry to prison and passive casefinding (self-referral) of TB suspects while in prison. Importantly, however, these control activities were inconsistently applied across facilities due to a range of factors including lack of human resources for health, poor health education among both officers and inmates and lapsed awareness of health protocols among prison health professionals.
TB diagnosis
After a diagnostic workup, a clinician made an initial TB diagnosis based on the inmate's history and physical examination, smear microscopy results and chest X-ray (CXR). Further assessment and revised diagnoses were made upon availability of culture results for inmates who had not been previously diagnosed. Based on these results, inmates were classified as (i) TB bacteriological confirmed cases (any smear or culture positive), (ii) TB clinical diagnosis (clinical signs or symptoms consistent with TB but smear and culture negative) and (iii) no TB diagnosis. Full details of the procedures for TB diagnosis may be found elsewhere [7, 8] . Drug susceptibility testing was done for all inmates, and referrals were made for drug-resistant cases to the University Teaching Hospital according to the National guidelines at that time. MDR Treatment in Zambia is available centrally.
TB treatment/follow-up
All inmates diagnosed with TB were referred to the Zambia National TB programme at health centres located within or nearby each prison to initiate treatment according to National Guidelines and under the responsibility of the local clinical staff. Delivery of drugs to inmates was done on a daily basis. Nurses, treatment supporters and/or TB/HIV peer educators from the government health centres brought the required TB drugs into the prisons every morning and TB patients received their medication by Direct Observed Therapy (DOT). All inmates diagnosed with TB were followed up at the respective TB treatment clinic according to national guidelines. However, the study was not able to assess treatment outcomes for drug-resistant cases.
Data collection
We retrospectively reviewed the national TB treatment records for inmates diagnosed under the programme between October 2010 and September 2011 and who were expected to have completed TB treatment by April 2012. A report was generated using the TB REACH programme database of all inmates diagnosed with TB during this period. We then compared this list with the National TB treatment registers at the primary health centres serving the six prisons and recorded all outcomes found in the registers. We attempted to track inmates who were not documented in the TB registers or who had their names documented but no treatment outcome and were no longer in prison using home addresses and/ or phone numbers collected as locator information from their medical files.
Ethical review
This project was reviewed by the Biomedical Research Ethics Committee of the University of Zambia (001-03-11) and the Institutional Review Board (IRB) of the University of Alabama at Birmingham (F101014011), USA. Both institutions waived informed consent as TB (Table 2 ). There were seven cases of extrapulmonary TB and one case of MDR TB. TB treatment initiation was documented in 345 of 374 (92%) inmates diagnosed with TB. Of those that initiated treatment, 66% were cured or completed treatment, 5% died and 29% were lost to follow-up. Among those lost to follow-up, 11% were released into the community and 13% were transferred to another prison. No documentation was found for the remaining 5%.
Treatment outcomes by facility
Rates of treatment initiation differed across prison facilities. At Lusaka Central, 157/175 (90%) of inmates diagnosed with TB during the programme period were initiated on anti-TB treatment (ATT). In the largest of the Kabwe Complex facilities, the male maximum secu- 
Discussion
This study demonstrates different patterns of TB continuity of care in six prisons in Zambia. The different physical infrastructure, inmate release and transfer profiles, and even health service availability, form the backdrop for these variable treatment outcomes. While in general the initiation of ATT in TB-diagnosed inmates across the different facilities was high (89-100%), great variability was identified in rates of treatment completion (50-86%), deaths (0-8%) and loss to follow-up (7-43%). A central albeit unsurprising finding was that prisons with a larger proportion of remandees and consequently higher rates of interp-rison transfer and release (Lusaka Central and Kabwe Complex) also experienced higher rates of loss to follow-up from TB care and treatment. It is possible that some of those who were lost to follow-up sought care and continued their treatment, but we were unable to confirm this. Given the extremely high rates of loss to follow-up due to transfers and releases, it is difficult to interpret the other TB treatment outcomes. Unsurprisingly, the rates of cure and completion in the same sites were comparatively lower.
In 2013, the Zambian national TB programme reported a successful completion rate of 85% for new and relapse cases, and 27% for MDR TB; lost to followup was 4% [6] . However, although this is encouraging, until there is better tracking of released and transferred inmates, their outcomes cannot be compared to those of the general population.
Breakdowns in the TB treatment care identified in this study are reflective of the generally fragile nature of the Zambian prison health system. Key barriers include the overcrowding and high inmate-to-officer ratios that make monitoring of individual health conditions physically challenging [10] . As in the civilian health system, frequent transfers make tracking of inmate-patients difficult. Health personnel in charge of patients are typically not informed of the pending transfers and are unable to prepare referral forms. Transferred inmates are not allowed to move with their paper medical records, and receiving facilities have no way of knowing who, among incoming inmates, is on TB or other treatment [11] . The onus is thus placed on the inmate-patient to ensure that their treatment plan is noted and continued. In the Zambian prison setting, as elsewhere in the region inmates' ability to voice such needs may be limited [10, 12] . Lack of a functional medical record system that links prison facilities to each other or to the mainstream health information system forms a critical backdrop to this problem and is a major contributor to such breakdowns [11] .
The highest initiation and completion and/or cure rates were reported in Kabwe Maximum prison, the site which had the most stable inmate population (convicted prisoners with a minimum 7 year sentence) and an internal prison-run health clinic. Notably, this facility also experienced the highest proportion of deaths (8%). This likely reflects an under-reporting of deaths among diagnosed inmates at other facilities as many were lost to follow-up. However, it is also possible that the inmates at Kabwe Maximum had overall poorer health or were diagnosed later in the course of their TB disease because they had been in prison for longer periods of time.
The Global Plan to Stop TB encourages screening, early detection and treatment of TB in all congregate settings including prisons [13] . Although it would be easy to assume that implementation of TB screening with achievement of complete ATT coverage and positive treatment outcomes is a straightforward exercise in the closed setting of prisons, the reality is more complex. Our findings, while open to interpretation, flag the potential impact of previously identified challenges to delivering TB treatment to a differentiated and paradoxically mobile prison population in a service environment that makes ensuring even basic service continuity a challenge. Nor are these findings exceptional to low-income settings, with a recent study of TB in UK prisons demonstrating very low proportions of diagnosed TB successfully completing treatment (48%) and high rates (20%) of lost to follow-up [14] .
Our study findings flag the urgent need for a range of system strengthening measures for health servicesincluding but not exclusive to TB -in Zambian prisons. Specific to TB, there is a need for infection control practices, rapid diagnostics, isolation facilities and more effective and shorter treatment regimens [9, 10] . Applicable to TB but also needed more generally are radical and concurrent improvements in a range of systems components including implementation and monitoring of a basic package of facility-level primary health services to improve case-finding and surveillance, a functional health information system to ensuring patient monitoring within and between services, adequate medical commodities including medications and diagnostic tests and, fundamentally, human resources for health with both technical and operational capacity [10] . While often addressed in isolation (e.g. through brief in-service training to improve knowledge of TB diagnosis and treatment among health workers), these components are all equally important elements of a health system capable of providing routine and sustained access to high-quality health services [15, 16] . Such a 'systems' perspective is supported by the combined experience of the authors and suggests that NGOs, while important partners to the prison service and capable of providing catalytic support, are ill-positioned to take the place of government in providing routine ongoing prison health care, as (unlike in the general community) access is only possible with government permission [11] .
Our findings support previous work that indicates the need for reforms both internal and external to prisons to improve prison health and TB outcomes [17] . Strategies for minimising loss to follow-up among inmates on ATT, for example, could include inmate peer educator services to improve linkages, or delaying or better coordinating prison transfers [18] . Externally, a range of upstream interventions could reduce overcrowding and the pressure on prison health services [10] [11] [12] . Such interventions might include criminal justice system reform such as reducing rates of arbitrary arrest, improving the efficiency of the judicial system or introducing community sentencing to minimise remandees housed in Zambian prisons [19] . The judiciary and ministries involved with inmate welfare should also work in collaboration to ensure inmates on TB treatment are identified prior to their release or transfer so an appropriate referral link to a general community or prisons health facilities is made. Improving these internal and external systems will also benefit the community at large by preventing transmission of disease from recently released inmates to others in the general community.
Limitations
Several limitations are associated with the retrospective nature of this work and the inherent challenges of working within a prison setting. Medical records and registers have missing information due to poor documentation, in particular for inmates who were either released or transferred. Lack of documentation could have resulted in an overestimation of the number of lost to follow-up. We attempted to minimise the effect of this problem by searching for records from the prisons and the clinic facility and to contact inmates either via phone or in person using available contact information. Although we are not aware of such programmes, it is possible that the differences in environmental conditions and/or service availability in the various facilities in this study may have been influenced by other projects (Zambia Prisons Service or non-government sponsored) that we were unable to account for. It is also possible that the TB diagnosis is overrepresented due to the initial clinical diagnosis made by the clinical officers and the geographic distribution of inmates (rural and urban). This could lead to an underrepresentation of HIV-infected rates among the TB affected inmate population compared to the national average.
Conclusion
Weak health systems within the Zambian prison service currently undermine continuity of care for TB infected inmates. This is despite the implementation of several intensive TB screening and case-finding interventions in the recent past. To prevent TB transmission and the development of drug resistance in this vulnerable population, it is necessary to strengthen systems based on sufficient and competent human resources for health, good health information systems including electronic record keeping for prison facilities and standard operating procedures that will guide timely treatment initiation and completion.
